Bonstein Sara
Insmed Incorporated · Chief Financial Officer
Bonstein Sara is listed in filings as Chief Financial Officer at Insmed Incorporated. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Insmed Incorporated (INSM), scPharmaceuticals Inc. (SCPH), and Xilio Therapeutics, Inc. (XLO). The current snapshot covers public activity from Jun 13, 2024 to Jun 5, 2026. Reported amounts are shown as $245.9K to $116.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $961k8.3k shares | SellMay 13, 2026 | $116.18 | $109.81 | |
| $117k748 shares | SellFeb 3, 2026 | $156.34 | $109.81 | |
| $252k1.4k shares | SellJan 8, 2026 | $174.17 | $109.81 | |
| $294k1.7k shares | SellJan 7, 2026 | $175.07 | $109.81 | |
| $263k1.5k shares | SellJan 6, 2026 | $173.33 | $109.81 |